Episode 60: Improving Care and Raising Awareness for NMOSD

Episode 60 of the NeurologyLive^® Mind Moments™ podcast is now live! Scroll down to listen or click here to subscribe on your favorite streaming service.

The Mind Moments™ podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis (MS), Parkinson disease, dementia, sleep disorders, and more.

Episode 60, "Improving Care and Raising Awareness for NMOSD," features an exclusive interview with Friedmann Paul, MD, head, Clinical Neuroimmunology Research Group, NeuroCure Clinical Research Center, and head, Clinical and Experimental Neuroimmunology, Experimental and Clinical Research Center, Charité–Universitätsmedizin Berlin. He shared his perspective on the state of care in neuromyelitis optica spectrum disorder (NMOSD), the need to raise awareness for symptomatic care and patient challenges, and the potential of novel therapeutic approaches to improve care and possibly cure the disorder.

The stories highlighted in this episode's Neurology News Minute can be found here:

• Donepezil Transdermal System Wins FDA Approval to Treat Alzheimer Disease Dementia
• Sarepta Details Phase 3 EMBARK Study in DMD
• Ganaxolone Wins Landmark Approval for CDKL5 Deficiency Disorder

Click here to subscribe to the Mind Moments™ podcast. Be sure to leave a rating and review for the show. Thanks for listening!